[1] DevarbhaviH, Asrani S K, Arab J P, et al. Global burden of liver disease: 2023 update[J].J Hepatol,2023,79(2):516-537.
[2] 闵颖,佟静,王炳元,等.酒精性肝炎相关的慢加急性肝衰竭[J].中国医学前沿杂志(电子版),2023,15(2):12-17.
[3] LiY M, Fan J G, National Workshop on Fatty Liver and Alcoholic Liver Disease, er al. Guidelines of prevention and treatment for alcoholic liver disease (2018, China)[J]. J Dig Dis, 2019,20(4):174-180.
[4] 李佳琪,李君.慢加急性肝衰竭:定义、诊断与发病机制[J].中华肝病杂志,2022,30(2):121-126.
[5] 方志红,崔剑巍,胡义扬,等.酒精性肝病的内毒素损伤机制[J].中华肝脏病杂志,2005,13(8):636-638.
[6] HaqueA U, Aan N U. Leukemoid reaction. Unusual causes[J].Int J Pathol, 2010,8:39-40.
[7] PortichJ P, Faulhaber G A M. Leukemoid reaction: a 21st-century cohort study[J]. Int J Lab Hematol,2020,42(2):134-139.
[8] 陈炳芳,张银,孙静,等.食管静脉曲张破裂出血患者合并类白血病反应1例[J].世界华人消化杂志,2017,25(35):3167-3170.
[9] 王晓昊,李世颖,但雪莲,等.酒精性肝衰竭合并类白血病反应1例[J]. 中华肝脏病杂志,2020,28(10):882-884.
[10] OsnaN A, Donohue T M Jr, Kharbanda K K. Alcoholic liver disease: pathogenesis and current management[J]. Alcohol Res,2017,38(2):147-161.
[11] MargolesL M, Mittal R, Klingensmith N J, et al. Chronic alcohol ingestion delays T cell activation and effector function in sepsis[J]. PLoS One,2016,11(11):e0165886.
[12] 许影,赵金明,张飞宇,等.酒精性肝病合并脓毒症的研究进展[J].中华全科医师杂志,2020,19(8):748-752.
[13] RuiF, Yang H, Guo Z, et al. Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients[J].J Viral Hepat,2021,28(12):1719-1728. |
